|
GOPC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62614366416847E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.24114085465044E-12 |
| Normal-vs-Stage2 |
7.89640000053993E-08 |
| Normal-vs-Stage3 |
1.50990331349021E-13 |
| Normal-vs-Stage4 |
2.97550872829788E-12 |
| Stage1-vs-Stage2 |
7.298000E-01 |
| Stage1-vs-Stage3 |
1.847830E-02 |
| Stage1-vs-Stage4 |
7.623500E-03 |
| Stage2-vs-Stage3 |
2.021000E-01 |
| Stage2-vs-Stage4 |
1.072790E-01 |
| Stage3-vs-Stage4 |
6.501400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.66133814775094E-16 |
| Normal-vs-AfricanAmerican |
3.428000E-04 |
| Normal-vs-Asian |
1.30880000170919E-08 |
| Caucasian-vs-AfricanAmerican |
2.245600E-01 |
| Caucasian-vs-Asian |
7.302400E-01 |
| AfricanAmerican-vs-Asian |
4.087200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.34812169708221E-13 |
| Normal-vs-Female |
1.68742797512778E-12 |
| Male-vs-Female |
3.595400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.4043990676812E-11 |
| Normal-vs-Age(41-60Yrs) |
1.31872290864976E-12 |
| Normal-vs-Age(61-80Yrs) |
2.9082292130056E-12 |
| Normal-vs-Age(81-100Yrs) |
1.180930E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.875610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.034400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.105400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.261800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.572600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.821200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.891930E-02 |
| Classical-VS-Follicular |
6.193000E-01 |
| Classical-VS-Other |
8.885600E-01 |
| Classical-VS-Normal |
1.67776903481354E-12 |
| Tall-VS-Follicular |
1.053780E-02 |
| Tall-VS-Other |
1.757550E-01 |
| Tall-VS-Normal |
2.17089679566129E-11 |
| Follicular-VS-Other |
9.662600E-01 |
| Follicular-VS-Normal |
1.58259999993859E-07 |
| Other-VS-Normal |
1.250360E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.92834637147143E-12 |
| Normal-vs-N1 |
4.89399631931065E-11 |
| N0-vs-N1 |
3.387400E-01 |
|
|
